EMN Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
2.5B
+15.4%
2.2B
+10.3%
2.0B
-10.4%
2.2B
-3.7%
2.3B
Cost of Revenue
2.0B
+11.9%
1.7B
+6.8%
1.6B
-7.6%
1.8B
-0.7%
1.8B
Gross Profit
560.0M
+29.9%
431.0M
+27.5%
338.0M
-21.9%
433.0M
-14.4%
506.0M
Operating Expenses
251.0M
+9.1%
230.0M
-8.0%
250.0M
+3.3%
242.0M
+2.1%
237.0M
R&D
65.0M
+8.3%
60.0M
+3.4%
58.0M
-7.9%
63.0M
-6.0%
67.0M
SG&A
185.0M
+3.9%
178.0M
+11.9%
159.0M
-0.6%
160.0M
+1.9%
157.0M
Operating Income
309.0M
+53.7%
201.0M
+128.4%
88.0M
-53.9%
191.0M
-29.0%
269.0M
EBITDA
442.0M
+29.6%
341.0M
+24.9%
273.0M
-19.7%
340.0M
-16.9%
409.0M
Net Income
184.0M
+72.0%
107.0M
+1.9%
105.0M
+123.4%
47.0M
-66.4%
140.0M
EPS (Basic)
$1.60
+72.0%
$0.93
+1.1%
$0.92
+124.4%
$0.41
-66.4%
$1.22
EPS (Diluted)
$1.59
+71.0%
$0.93
+1.1%
$0.92
+130.0%
$0.40
-66.7%
$1.20
Shares (Diluted)
115.3M
+0.3%
115.0M
+0.6%
114.3M
-1.0%
115.4M
-0.7%
116.2M
Eastman Chemical (EMN) โ€” Financials